Video Experimental Relacionado
Updated: Jul 17, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Hipoinsulinemia, intolerancia a la glucosa y disminución del tamaño de las células beta en ratones con deficiencia de
Nature
|January 5, 2001
Resumen
Los ratones que carecen de S6 quinasa 1 muestran niveles reducidos de insulina y intolerancia a la glucosa. Esto se debe a las células beta pancreáticas más pequeñas, no a la resistencia a la insulina, imitando la diabetes tipo 2.
Área de la Ciencia:
- El metabolismo es el metabolismo.
- Endocrinología Endocrinología.
- Biología Molecular Biología Molecular
Sus antecedentes:
- La insulina regula la homeostasis de la glucosa a través de los sustratos de los receptores de insulina (IRS-1, IRS-2) y distintas vías de señalización.
- Los efectores que median estas vías y sus roles en la homeostasis de la glucosa no se comprenden completamente.
Objetivo del estudio:
- Para investigar el papel de la S6 quinasa 1 (S6K1), un efector de la vía de la fosfatidilinositida-3-OH quinasa (PI3K), en la homeostasis de la glucosa y la secreción de insulina.
Principales métodos:
- Se generaron y analizaron ratones con deficiencia de S6 quinasa 1.
- Se evaluó la tolerancia a la glucosa, los niveles de insulina, la secreción de insulina y la masa y el tamaño de las células beta pancreáticas.
Principales resultados:
- Los ratones con deficiencia de S6 quinasa 1 presentan hipoinsulinemia y intolerancia a la glucosa.
- Estos ratones muestran una reducción de la secreción de insulina inducida por la glucosa y el contenido de insulina pancreática, vinculada a una disminución de la masa endocrina pancreática y un tamaño más pequeño de las células beta.
- La resistencia a la insulina no se observó en el tejido muscular aislado.
Conclusiones:
- La S6 quinasa 1 juega un papel crítico en el mantenimiento de la masa y la función de las células beta pancreáticas.
- La deficiencia de S6K1 conduce a un fenotipo que se asemeja a la diabetes tipo 2 preclínica, destacando su importancia en la homeostasis de la glucosa.
Videos de Conceptos Relacionados
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

